首页> 外文期刊>Respirology : >Endobronchial ultrasound-guided transbronchial needle aspiration for diagnosis of sarcoidosis in clinically unselected study populations
【24h】

Endobronchial ultrasound-guided transbronchial needle aspiration for diagnosis of sarcoidosis in clinically unselected study populations

机译:支气管内超声引导下经支气管针吸术诊断未选临床人群的结节病

获取原文
获取原文并翻译 | 示例
           

摘要

Literature suggests that ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has excellent performance characteristics for diagnosis of sarcoidosis. However, many authors challenge the external validity of EBUS-TBNA results, as most studies were performed in referral centres by highly experienced investigators, and included populations with very high sarcoidosis prevalence. We performed a systematic review and meta-analysis to estimate the role of EBUS-TBNA for diagnosis of sarcoidosis in studies enrolling consecutive patients with lymphadenopathy detected at imaging studies, regardless of the suspected underlying clinical aetiology. The Pubmed, Embase, Cinahl, Web of Science and Cochrane Library databases were screened to identify the pertinent literature. Quality of eligible studies was assessed by Quality Assessment, Data Abstraction and Synthesis-2 criteria. Pooled diagnostic yield, sensitivity and specificity were calculated, and a summary receiver operating characteristic curve was constructed. Subgroup analysis was planned to identify possible sources of study heterogeneity. Fourteen studies, collectively involving 2097 patients, fulfilled eligibility criteria. The median prevalence of sarcoidosis was 15%. EBUS-TBNA had a pooled diagnostic yield of 0.79 (standard deviation, 0.24), a pooled sensitivity of 0.84 (95% confidence interval (CI), 0.79-0.88) and a pooled specificity of 1.00 (95% CI, 0.99-1.00). Only subgroup analysis exploring the influence of study design seemed to influence the observed inter-study heterogeneity for sensitivity, retrospective studies showing worst sensitivity than prospective ones. The results of EBUS-TBNA for diagnosis of sarcoidosis in clinically unselected populations are excellent and compare favourably with published results from studies conducted in selected populations. High-quality trials would be needed to evaluate factors possibly explaining the observed heterogeneity in sensitivity.
机译:文献表明,超声引导下经支气管针吸(EBUS-TBNA)在结节病的诊断中具有出色的性能特征。但是,许多作者都对EBUS-TBNA结果的外部有效性提出质疑,因为大多数研究都是由经验丰富的研究人员在转诊中心进行的,其中包括结节病患病率很高的人群。我们进行了系统的回顾和荟萃分析,以评估EBUS-TBNA在影像学研究中连续入选淋巴结病患者的研究中诊断结节病的作用,而不论潜在的临床病因是什么。筛选了Pubmed,Embase,Cinahl,Web of Science和Cochrane图书馆数据库,以鉴定相关文献。通过质量评估,数据抽象和Synthesis-2标准评估合格研究的质量。计算合并的诊断产量,敏感性和特异性,并构建汇总的受体工作特征曲线。计划进行亚组分析以识别研究异质性的可能来源。共有2097名患者参与的14项研究符合入选标准。结节病的中位患病率为15%。 EBUS-TBNA的合并诊断产率为0.79(标准偏差,0.24),合并敏感性为0.84(95%置信区间(CI),0.79-0.88),合并特异性为1.00(95%CI,0.99-1.00) 。只有探讨研究设计影响的亚组分析似乎会影响观察到的研究间异质性,而回顾性研究显示,其敏感性低于前瞻性。 EBUS-TBNA在临床未选择的人群中诊断结节病的结果非常好,与在选定的人群中进行的研究发表的结果相比具有优势。需要高质量的试验来评估可能解释所观察到的敏感性异质性的因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号